{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-033784","form_type":"8-K","ticker":"FHTX","cik":"0001822462","company_name":"Foghorn Therapeutics Inc.","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.143141+00:00","generated_at":"2026-05-18T10:25:11.076609+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Foghorn Therapeutics signs new 9-year lease for 72,846 sq ft HQ in Watertown, MA, terminates Cambridge lease","bullets":["New lease at 99 Coolidge Avenue, Watertown for 72,846 sq ft; annual base rent starts at $87/sq ft with partial abatement in years 1-2.","Rent commencement expected October 1, 2026, followed by 3% annual escalations starting October 1, 2027.","Terminates 81,441 sq ft lease at 500 Technology Square, Cambridge (originally through Sept 2028) via Lease Termination Agreement.","Security deposit of $2 million; two 5-year renewal options; space for HQ and R&D operations.","Early occupancy of office portion targeted for December 15, 2025, with full delivery of build-out by December 15, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-033784","json":"https://secwatch.observer/filing/0001628280-25-033784.json","markdown":"https://secwatch.observer/filing/0001628280-25-033784.md","text":"https://secwatch.observer/filing/0001628280-25-033784.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822462/000162828025033784/0001628280-25-033784-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822462/000162828025033784/fhtx-20250627.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T10:25:11.076609+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}